Dr. Okuda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8800Fax+1 214-645-8238
Education & Training
University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2004 - 2006
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 2001 - 2004
Creighton University School of Medicine (Phoenix)Internship, Internal Medicine, 2000 - 2001
University of Hawaii, John A. Burns School of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2002 - Present
CA State Medical License 2004 - 2026
TX State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) Start of enrollment: 2016 Mar 19
Publications & Presentations
PubMed
- Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis.Burcu Zeydan, Christina J Azevedo, Naila Makhani, Mikael Cohen, Melih Tutuncu
CNS Drugs. 2024-12-01 - How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder.Edgar Carnero Contentti, Dalia Rotstein, Darin T Okuda, Friedemann Paul
Multiple Sclerosis. 2024-11-05 - Clinical characteristics and disease burden of African, Caribbean, and Black people with multiple sclerosis in Toronto, Canada.Andrea M Kuczynski, Ashley Jones, Dorlan Kimbrough, Alexandra Muccilli, Chantal Roy-Hewitson
Multiple Sclerosis and Related Disorders. 2024-10-01
Press Mentions
How a Pioneering Diabetes Drug Offers Hope for Preventing Autoimmune DisordersFebruary 15th, 2023- Biomarkers, Diet, Progressive MS, and Epstein-Barr Virus Among Research News Shared at ECTRIMSNovember 4th, 2022
- Can First MS Symptoms Be Delayed?October 31st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
